Our Story

When the founder of ConceptoMed, M.D. Christian Mide, performed arthrocentesis procedures, with repeated disconnections of the syringe from a firmly attached needle placed inside a knee, he felt the need for a “crowbar” to ease the disconnection, improve aseptic safety and reduce patient pain.

The medical need quickly emerged into a potential product idea and became the base for the LuerJack technology and the foundation of ConceptoMed.

Today ConceptoMed consists of a strong team of innovative and dedicated professionals with strong educational background and international experience located at our sites at Lofoten Islands, Norway (HQ), Oslo, Norway and Jönköping, Sweden. We create smart medtech systems that empower healthcare professionals and  improve patient care.  So far we have launched two medical device product groups with global potential from our strong pipeline.

The Luer-Jack Idea
Image of the first proof of concept by using a bent paper-clip to leverage.

Key Company Milestones

ConceptoMed was founded

Substantial development and design work in collaboration with K8 Industridesign

2012

First patent granted for LuerJack

2014

The Intervention Centre at Oslo University Hospital issued a positive evaluation report of LuerJack

Signed first distribution agreement for LuerJack

Received European approval (CE Mark) for the LuerJack syringe

International sales and market department established in Oslo

Branch office established in Oslo, Norway

2015

Major equity round in an oversubscribed private placement of NOK 100 Million

First patent granted for LuerJack Lock

Branch office established in Jönköping, Sweden

First US patent issued for LuerJack

ConceptoMed named a global ‘Disrupt 100’ company

ConceptoMed receives ISO13485 certification

Signed Distribution agreements for a total of 16 countries in Europe and the Middle East

European and Australian patent granted for LuerJack

ConceptoMed named “Company of the year 2016” by Norway Healthtech

2016

FDA 510(k) clearance for first LuerJack Slip

Granted patents for LuerJack in Japan

Granted patent for LuerJack in China, Hong Kong, Singapore, Mexico

FDA 510(k) clearance for LuerJack Slip and Lock

Launch of LuerJack in soft blister in Europe

Automated manufacturing under installation in Sweden

2017
2012

ConceptoMed was founded

Substantial development and design work in collaboration with K8 Industridesign

2014

First patent granted for LuerJack

2015

The Intervention Centre at Oslo University Hospital issued a positive evaluation report of LuerJack

Signed first distribution agreement for LuerJack

Received European approval (CE Mark) for the LuerJack syringe

International sales and market department established in Oslo

Branch office established in Oslo, Norway

2016

Major equity round in an oversubscribed private placement of NOK 100 Million

First patent granted for LuerJack Lock

Branch office established in Jönköping, Sweden

First US patent issued for LuerJack

ConceptoMed named a global ‘Disrupt 100’ company

ConceptoMed receives ISO13485 certification

Signed Distribution agreements for a total of 16 countries in Europe and the Middle East

European and Australian patent granted for LuerJack

ConceptoMed named “Company of the year 2016” by Norway Healthtech

2017

FDA 510(k) clearance for first LuerJack Slip

Granted patents for LuerJack in Japan

Granted patent for LuerJack in China, Hong Kong, Singapore, Mexico

FDA 510(k) clearance for LuerJack Slip and Lock

Launch of LuerJack in soft blister in Europe

Automated manufacturing under installation in Sweden